Biosensor Techniques for Mycobacterium Tuberculosis Detection

Biosensor technologies for the detection of Mycobacterium tuberculosis (M. tuberculosis) have evolved rapidly to address the limitations of conventional diagnostics, which often require lengthy culture periods and centralised laboratory infrastructure. Modern biosensors integrate biological recognition elements—such as antibodies, nucleic acid probes or aptamers—with sensitive transduction platforms to enable rapid, specific and quantitative detection. Key approaches include lateral flow immunoassays for antigen detection in diverse sample matrices, electrochemical sensors that transduce binding events into measurable current or impedance changes, and magnetic or optical biosensors that exploit nanomaterials for signal amplification. Recent advances focus on improving analytical sensitivity to the subnanomolar range, shortening assay times to minutes, and miniaturising devices for point-of-care use. These innovations hold particular promise for decentralised screening in resource-limited settings, where early and accurate diagnosis is critical to reducing transmission and guiding timely treatment.

Research from Nature Portfolio

Recent studies have introduced a magnetic barcode assay capable of sequence-specific detection of M. tuberculosis genes directly from processed sputum without culture. The platform captures amplified targets on microspheres, labels them with magnetic nanoprobes and quantifies binding by miniaturised nuclear magnetic resonance. This integrated cartridge completes sample-to-answer analysis within 2.5 hours, detects drug-resistance mutations and discriminates non-tuberculous species with high specificity. The compact format and low-cost instrumentation suggest potential for high-throughput, on-site screening in field clinics.

Biosensor Techniques for Mycobacterium Tuberculosis Detection publication trend

The graph below shows the total number of articles in biosensor techniques for mycobacterium tuberculosis detection across all publications each year (not limited to Nature Index journals).

Technical terms

Biosensor: An analytical device combining a biological recognition element with a signal transducer to detect specific analytes.

Lateral flow immunoassay (LFIA): A paper-based platform that uses capillary flow to transport a sample across antibody-conjugated nanoparticles for rapid visual detection.

Electrochemical biosensor: A sensor that converts a biological interaction into an electrical signal, measured as current, potential or impedance.

Magnetic barcode assay: A nucleic acid detection method in which target sequences are captured on magnetic microspheres and labelled with magnetic nanoparticles for quantification via nuclear magnetic resonance.

Limit of detection (LOD): The lowest concentration of an analyte that can be reliably distinguished from background noise.

References

1. Biosensing Technologies for Mycobacterium tuberculosis Detection: Status and New Developments. Journal of Immunology Research (2011).
2. Magnetic barcode assay for genetic detection of pathogens. Nature Communications (2013).
3. Development of Gold-Nanoparticle-Based Lateral Flow Immunoassays for Rapid Detection of TB ESAT-6 and CFP-10. Biosensors (2023).
4. Reduced Graphene Oxide/TEMPO‐Nanocellulose Nanohybrid‐Based Electrochemical Biosensor for the Determination of Mycobacterium tuberculosis. Journal of Sensors (2020).
5. MPT64 assays for the rapid detection of Mycobacterium tuberculosis. BMC Infectious Diseases (2021).